Why Berberine Absorption Is Tricky: What Different Formulas Are Trying to Solve

Two bottles can both say berberine on the front and still look quite different once you read what is inside. One might be a straightforward capsule. Another uses an oil-based softgel. Another adds ingredients such as a phosphatidylcholine-containing complex.

Those differences matter because berberine is difficult to deliver orally, and formulators have tried several ways to work around that problem. So when you compare our berberine range, the useful question is not simply which bottle lists the biggest number. It is also what the formula is trying to do around the berberine.

Why berberine is difficult to deliver orally

If you are asking how well berberine is absorbed, the short answer is: not very efficiently, and not for one single reason. Research points to a combination of poor solubility, limited intestinal permeability, transporter-related efflux and substantial metabolism in the intestine and liver.

In plain English, berberine can have trouble getting into solution, trouble crossing the intestinal wall, and trouble remaining unchanged long enough for much of the original dose to appear in the bloodstream. That is why berberine absorption has become such an active formulation topic.

It is also important not to confuse low plasma exposure with no biological activity. Berberine can interact with the gut environment, and metabolites may also contribute to its effects. Bioavailability is useful information, but it is not the whole story.

Barrier one: getting berberine into a form that can dissolve

Before an ingredient can be absorbed well, enough of it generally needs to be available in a dissolved form. Berberine has poor water solubility, so this first step can limit how much is available to cross the intestinal wall.

Formulation scientists can change the environment around an ingredient by using oils, phospholipids, dispersions or other delivery systems. The idea is to make a difficult ingredient easier to present to the body in an absorbable form.

That is a formulation goal, not proof that every specialised product works better in people. A meaningful absorption claim needs evidence on the specific formulation being discussed.

Barrier two: crossing the intestinal wall

Even when berberine is available in the gut, it does not cross the intestinal wall especially easily. This is the permeability part of the problem.

Berberine is also affected by P-glycoprotein, often shortened to P-gp. You can think of P-gp as one of the intestinal wall's transport systems. Instead of letting everything continue across, it can push some compounds back towards the gut. Berberine is one of the compounds affected by this efflux process.

That helps explain why berberine HCl absorption is not simply a matter of swallowing a stated milligram amount. The label dose and the amount measured in circulation are different questions.

Barrier three: what happens before much reaches circulation

Berberine is also extensively metabolised in the intestine and liver. That means a portion of what gets past the earlier barriers can be changed before much unchanged berberine reaches systemic circulation.

This is one reason researchers use pharmacokinetic measures such as AUC and Cmax when they test a new berberine formulation. They are looking at how much exposure a particular formulation produces, not just how many milligrams were swallowed.

What formulators are trying to change

A straightforward berberine HCl capsule

Swanson Berberine 400mg keeps the active formula simple, with 400 mg of berberine HCl per capsule. This style makes sense if you want berberine to be the clear focus and prefer a short active ingredient panel.

It does not try to turn the product into a specialised delivery system. Instead, it gives you a familiar berberine HCl format with straightforward dosing.

An oil-based softgel

NOW Berberine Glucose Support takes a different approach. It uses berberine HCl in a softgel with MCT oil, plus sunflower lecithin among the other ingredients. The MCT oil creates an oil-based delivery environment rather than a standard dry powder capsule.

This is a good example of why an MCT oil berberine product can look different on the shelf. We can say what the formula contains and why the format is interesting, but we would not assign a specific percentage improvement in absorption to the finished NOW product without human data on that exact formula.

Berberine with additional phospholipid-containing ingredients

Coyne Bio-Berberine Complex 500mg and Coyne Bio-Berberine Advanced each provide 500 mg of berberine HCl per capsule and also contain chromium plus Origine 8.

Origine 8 combines green tea extract with a phosphatidylcholine complex. In Bio-Berberine Complex 500mg, the formula provides 25 mg of Origine 8, while Bio-Berberine Advanced provides 125 mg. The important wording here is that the Origine 8 component contains phosphatidylcholine. We do not describe the berberine itself as liposomal, and we do not treat this as proof that the finished Coyne products deliver a specific increase in berberine absorption.

Why our berberine shelf uses more than one delivery style

We do not think every berberine customer needs exactly the same formula. Some people want the simplest ingredient panel possible. Others are specifically interested in how a product has been formulated or want additional ingredients alongside the berberine.

That is why we like having more than one approach in our range. Swanson Berberine 400mg is a focused berberine HCl capsule. NOW Berberine Glucose Support gives you an oil-based softgel with MCT oil. The two Coyne options, Bio-Berberine Complex 500mg and Bio-Berberine Advanced, pair 500 mg berberine HCl with chromium and Origine 8.

We think that variety is useful because it lets you choose what matters most to you without pretending there is one universal winner. You can keep things simple, choose an oil-based format, or explore a more built-out formula with additional ingredients.

Better absorption is not the same as better results

This is where the detail matters. In pharmacokinetic studies, researchers often look at AUC, which reflects overall measured exposure over time, and Cmax, the highest measured concentration after a dose.

Human studies have shown that specific enhanced-delivery berberine formulations can produce higher measured exposure than the comparison berberine used in those studies. A 2023 pilot study of a LipoMicel berberine formulation reported higher AUC and Cmax than an unformulated comparator. A separate 2021 crossover study of a food-grade berberine Phytosome formulation also reported higher berberine exposure than unformulated berberine.

Those results are useful because they show that formulation can matter. They do not prove that every product using oil, phospholipids, liposomal language or another specialised format will behave the same way.

Higher exposure from one tested formulation also does not automatically establish better health outcomes, better tolerance, the best formula for every person, equivalence between different products, or a lower dose being interchangeable with a higher dose of another product.

That is why we keep product-specific claims tied to product-specific evidence. The LipoMicel and Phytosome studies above tested their own formulations. Their numerical results should not be transferred to the Swanson, NOW or Coyne products simply because some formulation ideas sound similar.

What to keep in mind before choosing

Start with the label. Check that the form and amount of berberine are clear, then look at whether the extra ingredients make sense for what you want from the formula. Serving directions matter too, especially if you prefer fewer capsules or need to take a product with meals.

Digestive tolerance can also be a practical factor. Berberine can cause gastrointestinal effects such as nausea, diarrhoea, bloating or constipation in some people.

Berberine may interact with medicines. If you take prescription medicines, including medicines used for blood glucose, talk with your pharmacist, GP or another qualified health professional before adding berberine. Berberine is not recommended during pregnancy or breastfeeding.

For broader questions about amounts used in studies, general benefits, side effects and safety, see our complete NZ berberine guide.

Common questions

Why is berberine poorly absorbed?

Berberine faces several barriers at once: it does not dissolve especially well, it crosses the intestinal wall poorly, transport proteins can push some of it back towards the gut, and a substantial amount is metabolised before much reaches the circulation.

How much berberine is actually absorbed?

There is no single percentage that applies to every person and every product. Reviews often describe oral berberine bioavailability as very low and sometimes cite figures below 1%, but much of the commonly repeated percentage comes from pharmacokinetic research that includes animal evidence. Human exposure also depends on the exact formulation and dose.

Does MCT oil improve berberine absorption?

MCT oil can be used as part of an oil-based delivery format, and NOW Berberine Glucose Support includes MCT oil for that reason. However, we would not attach a specific absorption increase to this finished product without human pharmacokinetic data on the exact formula.

Are phospholipid or liposomal berberine formulas better absorbed?

Some specific enhanced-delivery berberine formulations have produced higher AUC and Cmax values in human pharmacokinetic studies. That does not mean every phospholipid or liposomal product performs the same way. The exact formulation matters, and results from a studied Phytosome or LipoMicel product should not be transferred to a different supplement.

Is berberine HCl poorly absorbed?

Yes, standard berberine HCl still faces the same broad oral delivery challenges, including solubility, limited intestinal permeability, efflux and metabolism. HCl is a common supplement form, but the salt form does not remove all of those barriers.

Does better bioavailability mean better results?

Not automatically. Better bioavailability means a formulation produced greater measured exposure under the conditions tested. It does not by itself prove better health outcomes, better tolerance or that the formula is the best fit for every person.

Do I need an enhanced-absorption berberine formula?

Not necessarily. A straightforward berberine HCl capsule may suit you if you want a simple ingredient panel, while an oil-based or more complex formula may appeal if you are specifically interested in delivery design or added ingredients. Check the amount, serving directions, extras, tolerance and medicine cautions before choosing.

References

• Cui Y, et al. Research progress on pharmacological effects and bioavailability of berberine. PubMed PMID 38888754.
• Solnier J, et al. Characterization and Pharmacokinetic Assessment of a New Berberine Formulation with Enhanced Absorption In Vitro and in Human Volunteers. PubMed PMID 38004546.
• Petrangolini G, et al. Development of an Innovative Berberine Food-Grade Formulation with an Ameliorated Absorption. PubMed PMID 34904017.
• National Center for Complementary and Integrative Health. Berberine and Weight Loss: What You Need To Know.
• Cheng H, et al. Interactions between gut microbiota and berberine, a necessary procedure to understand the mechanisms of berberine. PubMed PMID 36105164.
• Wang K, et al. The metabolism of berberine and its contribution to the pharmacological effects. PubMed PMID 28290706.

Next steps

Once you know what each formula is trying to do, comparing berberine products becomes much easier. Our current collection lets you look at straightforward berberine HCl capsules, an MCT oil softgel and formulas with additional phospholipid-containing ingredients side by side, then choose the style that fits you best.